🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label,single arm,Phase Ib study,in order to evaluate the sa...
Status
Terminated
Location
The First Affiliated Hospital of Guangxi Medical University
Start Date
2022-06-10
Trial ID
NCT04941404
Treatments Being Tested
This is a phase I study of TQ05105 tablets in subjects with Hemophagocytic ...
Status
Unknown
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2020-07-17
Trial ID
NCT04326348
Treatments Being Tested
TQ05105 is a JAK2 inhibitors and can be used to treat JAK2 target-related d...
Status
Completed
Location
West China Hospital ,Sichuan University
Start Date
2018-11-20
Trial ID
NCT04339400
Treatments Being Tested
TQ05105 is a class 1 new drug with a new chemical structure developed by Ch...
Status
Completed
Location
Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Start Date
2021-07-19
Trial ID
NCT05982106
Treatments Being Tested
Primary objective: To evaluate the effect of rabeprazole on the primary ph...
Status
Active Not Recruiting
Location
The Third Xiangya Hospital, Central South University
Start Date
2026-07-20
Trial ID
NCT07608666
Treatments Being Tested
This is an open, multi-center clinical study designed to evaluate the effic...
Status
Recruiting
Location
Anhui Provincial Hospital
Start Date
2024-05-07
Trial ID
NCT06300320
Treatments Being Tested
Q05105 tablet is a Janus kinase 2 (JAK2) inhibitor, which can be used to tr...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2021-11-11
Trial ID
NCT05020652
Treatments Being Tested
This is an open-label, single-arm, multi-center phase II study consisting o...
Status
Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China
Start Date
2026-06-18
Trial ID
NCT07551427
Treatments Being Tested
This is an open, single-arm, multi-center clinical study designed to evalua...
Status
Terminated
Location
The Second People's Hospital of Hefei
Start Date
2024-05-13
Trial ID
NCT06245941
Treatments Being Tested
This is an open, open-label, parallel, single-dose, phase I clinical study ...
Status
Completed
Location
The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital)
Start Date
2024-10-12
Trial ID
NCT06598956
Treatments Being Tested